ANTA BARBARA, Calif.–QAD Inc. (NASDAQ: QADI), a leading provider of enterprise software and services for global manufacturers, and its partner Strategic Information Group (Strategic), announced today that Nexus Dx, a California-based life sciences company, has successfully gone live, on time and on budget, with QAD Enterprise Applications.
Based in San Diego, CA, Nexus Dx develops Point of Care (POC) cardiac diagnostic solutions. The company’s product lines include rapid cardiac diagnostic test kits that aid in the diagnosis of several cardiovascular diseases. These diagnostic solutions give medical providers better information faster, enabling better patient care in urgent care situations.
To prepare its operations and processes for more efficient production, regulatory compliance, and future validation needs, Nexus Dx selected QAD Enterprise Applications, and Strategic, as its enterprise technology partner to assist with the implementation.
“I am very pleased with the people and the level of quality support we received from the Strategic team, particularly our Project Manager,” said Camellia Fitzgerald, director of Finance for Nexus Dx. “We found the Strategic people extremely knowledgeable. They kept us on track for a successful and speedy implementation during a very demanding and busy environment. And, not only did Strategic take our QAD systems live in only three months, they offered value-added solutions to all of our business processes.”
With QAD Enterprise Applications replacing a combination of basic systems, Nexus Dx was able to consolidate its critical data into a single source, and have the information technology infrastructure in place to support its projected growth. Moreover, the system’s user interface (QAD .NET UI), is expected to help speed Nexus Dx employees’ learning curve, and significantly enhance user effectiveness and productivity over the long run.
“The QAD ERP system was the best choice for Nexus Dx,” said Fitzgerald. “It delivers the critical business and industry capabilities we need and is adaptable to support key processes, including our quality control systems.”
QAD Enterprise Applications enable Life Sciences manufacturers to optimize operations, meet compliance requirements, manage product quality and create market opportunities. QAD Enterprise Applications is a comprehensive, fully integrated end-to-end solution that delivers robust functionality, essential compliance capabilities, better organizational efficiency and enhanced usability.
“QAD Enterprise Applications, with services and solutions from Strategic, gives Nexus Dx a flexible, cost-effective ERP solution to help them bring their products to market more quickly, while meeting regulatory requirements and managing risk,” said Doug Novak, President and CEO of Strategic.
Strategic provides consulting services in support of QAD applications to companies looking to better leverage their ERP investment. Strategic also offers specialized software validation products; the company’s Validation Toolkit helps with FDA CFR 21 Part 11 validation requirements, streamlining validation for regulatory compliance, and allowing companies to implement and upgrade QAD applications with speed and ease.
About Nexus Dx
Nexus Dx is a clinical diagnostics company working to improve patient care by providing the medical community with rapid and reliable information at Point of Care (POC). The company’s products are developed via internal development, partnerships and acquisitions using proprietary technology.
Strategic helps companies achieve their corporate goals with the application of enterprise technology. The company specializes in providing proven solutions for a full range of enterprise applications including ERP, CRM, and QMS. Strategic works with start-up, multi-national and market leading companies to implement their systems on time and on budget, and help them maximize the value of their enterprise technology. For more information, visit www.strategic.com.
QAD is a leading provider of enterprise applications for global manufacturing companies specializing in automotive, consumer products, electronics, food and beverage, industrial and life science products. QAD applications provide critical functionality for managing manufacturing resources and operations within and beyond the enterprise, enabling global manufacturers to collaborate with their customers, suppliers and partners to make and deliver the right product, at the right cost and at the right time. For more information about QAD, visit the QAD web site at www.qad.com.
Note to Investors: This press release contains certain forward-looking statements made under the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. A number of risks and uncertainties could cause actual results to differ materially from those in the forward-looking statements. These risks include, but are not limited to, evolving demand for the company’s software products and products that operate with the company’s products; the company’s ability to sustain license and service demand; the company’s ability to leverage changes in technology; the company’s ability to sustain customer renewal rates at current levels; the publication of opinions by industry and financial analysts about the company, its products and technology; the reliability of estimates of transaction and integration costs and benefits; the entry of new competitors or new offerings by existing competitors and the associated announcement of new products and technological advances by them; delays in localizing the company’s products for new or existing markets; the ability to recruit and retain key personnel; delays in sales as a result of lengthy sales cycles; changes in operating expenses, pricing, timing of new product releases, the method of product distribution or product mix; timely and effective integration of newly acquired businesses; general economic conditions; exchange rate fluctuations; and, the global political environment. In addition, revenue and earnings in the enterprise resource planning (ERP) software industry are subject to fluctuations. Software license revenue, in particular, is subject to variability with a significant proportion of revenue earned in the last month of each quarter. Given the high margins associated with license revenue, modest fluctuations can have a substantial impact on net income. Investors should not use any one quarter’s results as a benchmark for future performance. For a more detailed description of the risk factors associated with the company and the industries in which it operates, please refer to the company’s Annual Report on Form 10-K for fiscal 2009 ended January 31, 2009.